Amicus Therapeutics Ownership 2024 | Who Owns Amicus Therapeutics Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

107.44%

Insider Ownership

0.75%

Retail Ownership

-8.19%

Institutional Holders

257.00

Amicus Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VANGUARD GROUP INC9.56%0.01%28,204,309-288,177-1.01%332,246,759Mar 31, 2024
PERCEPTIVE ADVISORS LLC9.51%5.74%28,057,456--330,516,832Mar 31, 2024
AVORO CAPITAL ADVISORS LLC9.28%3.76%27,400,000--322,772,000Mar 31, 2024
BLACKROCK INC.7.74%0.01%22,849,449-138,690-0.60%269,166,511Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP6.37%0.04%18,803,6453,613,62123.79%221,506,938Mar 31, 2024
JPMORGAN CHASE & CO5.32%0.02%15,691,157-2,157,374-12.09%184,841,838Mar 31, 2024
JANUS HENDERSON GROUP PLC4.68%0.09%13,814,5142,307,38520.05%162,712,883Mar 31, 2024
REDMILE GROUP, LLC4.49%5.73%13,257,286-1,571,035-10.59%156,170,829Mar 31, 2024
STATE STREET CORP4.22%0.01%12,442,501-720,584-5.47%146,572,662Mar 31, 2024
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC3.90%0.35%11,526,279-120,747-1.04%135,779,567Mar 31, 2024
MORGAN STANLEY3.29%0.01%9,704,848-3,623,049-27.18%114,323,110Mar 31, 2024
PALO ALTO INVESTORS LP3.17%12.41%9,344,102-1,029,613-9.93%110,073,522Mar 31, 2024
MACQUARIE GROUP LTD2.40%0.09%7,070,733-144,277-2.00%83,293,000Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA2.29%0.09%6,767,373-227,224-3.25%79,865,954Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC2.10%0.01%6,210,736259,4414.36%73,172,564Mar 31, 2024
FIERA CAPITAL CORP1.77%0.18%5,222,329160,6853.17%61,519,036Mar 31, 2024
AMERICAN CENTURY COMPANIES INC1.63%0.04%4,800,899218,8324.78%56,554,590Mar 31, 2024
DEUTSCHE BANK AG\1.47%0.02%4,351,081-1,427,663-24.71%51,255,734Mar 31, 2024
NORTHERN TRUST CORP1.07%0.01%3,156,082311,33110.94%37,178,645Mar 31, 2024
MASSACHUSETTS FINANCIAL SERVICES CO /MA/0.89%0.01%2,641,537226,4479.38%31,117,306Mar 31, 2024

Amicus Therapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 9.56% of the company's total share outstanding, currently valued at $332.25M. The top 10 institutional shareholders own together 65.06% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PALO ALTO INVESTORS LP3.17%12.41%9,344,102-1,029,613-9.93%110,073,522Mar 31, 2024
PERCEPTIVE ADVISORS LLC9.51%5.74%28,057,456--330,516,832Mar 31, 2024
REDMILE GROUP, LLC4.49%5.73%13,257,286-1,571,035-10.59%156,170,829Mar 31, 2024
STEMPOINT CAPITAL LP0.52%4.82%1,547,141684,32679.31%18,225,321Mar 31, 2024
CM MANAGEMENT, LLC0.15%4.45%450,000--5,301,000Mar 31, 2024
SATURN V CAPITAL MANAGEMENT LLC0.30%4.24%898,381698,408349.25%10,582,928Mar 31, 2024
AVORO CAPITAL ADVISORS LLC9.28%3.76%27,400,000--322,772,000Mar 31, 2024
GREAT POINT PARTNERS LLC0.51%2.75%1,495,500215,00016.79%17,616,990Mar 31, 2024
NOVO HOLDINGS A/S0.85%2.03%2,500,000--29,450,000Mar 31, 2024
HEALTHINVEST PARTNERS AB0.09%1.81%252,307203,597417.98%2,972,176Mar 31, 2024
BIOIMPACT CAPITAL LLC0.24%1.36%718,9703,0870.43%8,469,467Mar 31, 2024
ALPHACENTRIC ADVISORS LLC0.06%1.24%175,00035,00025.00%2,061,500Mar 31, 2024
SECTORAL ASSET MANAGEMENT INC0.07%1.02%221,04464,27541.00%2,603,898Mar 31, 2024
RICE HALL JAMES & ASSOCIATES, LLC0.35%0.69%1,028,569-37,396-3.51%12,116,543Mar 31, 2024
AMBASSADOR ADVISORS, LLC0.09%0.58%273,5082,5150.93%3,221,924Mar 31, 2024
GRANITE INVESTMENT PARTNERS, LLC0.31%0.41%918,834918,834100.00%10,823,865Mar 31, 2024
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC3.90%0.35%11,526,279-120,747-1.04%135,779,567Mar 31, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP0.39%0.34%1,152,65688,8508.35%13,578,288Mar 31, 2024
OSTERWEIS CAPITAL MANAGEMENT INC0.16%0.33%484,060484,060100.00%5,702,227Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.08%0.33%226,723226,723100.00%2,670,797Mar 31, 2024

The largest Amicus Therapeutics shareholder by % of total assets is PALO ALTO INVESTORS LP. The company owns 9.34M shares of Amicus Therapeutics (FOLD), representing 12.41% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLINGTON MANAGEMENT GROUP LLP6.37%0.04%18,803,6453,613,62123.79%221,506,938Mar 31, 2024
JANUS HENDERSON GROUP PLC4.68%0.09%13,814,5142,307,38520.05%162,712,883Mar 31, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND0.74%0.09%2,176,6001,858,100583.39%25,640,348Mar 31, 2024
ABRDN PLC0.55%0.04%1,622,3991,622,399100.00%19,111,861Mar 31, 2024
CITADEL ADVISORS LLC0.46%0.00%1,351,1821,308,4113059.11%15,916,924Mar 31, 2024
GRANITE INVESTMENT PARTNERS, LLC0.31%0.41%918,834918,834100.00%10,823,865Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.32%0.02%956,200878,8001135.40%11,264,000Mar 31, 2024
SATURN V CAPITAL MANAGEMENT LLC0.30%4.24%898,381698,408349.25%10,582,928Mar 31, 2024
STEMPOINT CAPITAL LP0.52%4.82%1,547,141684,32679.31%18,225,321Mar 31, 2024
0.23%0.03%665,723665,723100.00%7,988,676Mar 31, 2024
INVESCO LTD.0.26%0.00%765,888600,212362.28%9,022,162Mar 31, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.44%0.06%1,313,170578,30378.69%15,469,143Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.19%0.01%556,363556,363100.00%6,553,956Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.21%0.04%613,391520,118557.63%7,225,746Mar 31, 2024
OSTERWEIS CAPITAL MANAGEMENT INC0.16%0.33%484,060484,060100.00%5,702,227Mar 31, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.27%0.05%802,500442,500122.92%9,453,450Mar 31, 2024
STEMPOINT CAPITAL LP0.14%0.03%400,000400,000100.00%120,000Mar 31, 2024
NORTHERN TRUST CORP1.07%0.01%3,156,082311,33110.94%37,178,645Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP0.22%0.06%643,385271,00572.78%7,579,000Mar 31, 2024
CITIGROUP INC0.25%0.01%733,136261,81855.55%8,636,341Mar 31, 2024

As of Mar 31 2024, Amicus Therapeutics's largest institutional buyer is WELLINGTON MANAGEMENT GROUP LLP. The company purchased 3.61M stocks of FOLD, valued at $221.51M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MORGAN STANLEY3.29%0.01%9,704,848-3,623,049-27.18%114,323,110Mar 31, 2024
ARTAL GROUP S.A.----2,500,000-100.00%-Mar 31, 2024
JPMORGAN CHASE & CO5.32%0.02%15,691,157-2,157,374-12.09%184,841,838Mar 31, 2024
REDMILE GROUP, LLC4.49%5.73%13,257,286-1,571,035-10.59%156,170,829Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.----1,556,540-100.00%-Mar 31, 2024
FINEPOINT CAPITAL LP----1,489,025-100.00%-Mar 31, 2024
DEUTSCHE BANK AG\1.47%0.02%4,351,081-1,427,663-24.71%51,255,734Mar 31, 2024
PALO ALTO INVESTORS LP3.17%12.41%9,344,102-1,029,613-9.93%110,073,522Mar 31, 2024
ARTAL GROUP S.A.0.34%0.30%1,011,776-1,014,588-50.07%11,918,721Mar 31, 2024
CUTTER CAPITAL MANAGEMENT, LP----947,418-100.00%-Mar 31, 2024
GOLDMAN SACHS GROUP INC0.45%0.00%1,341,890-780,855-36.79%15,807,464Mar 31, 2024
STATE STREET CORP4.22%0.01%12,442,501-720,584-5.47%146,572,662Mar 31, 2024
FMR LLC0.59%0.00%1,747,546-446,914-20.37%20,586,092Mar 31, 2024
BARCLAYS PLC0.12%0.00%348,937-378,838-52.05%4,110,000Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC0.20%0.01%588,635-334,410-36.23%6,934,120Mar 31, 2024
CAPTION MANAGEMENT, LLC----299,500-100.00%-Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC----295,500-100.00%-Mar 31, 2024
VANGUARD GROUP INC9.56%0.01%28,204,309-288,177-1.01%332,246,759Mar 31, 2024
NUVEEN ASSET MANAGEMENT, LLC0.39%0.00%1,147,544-255,028-18.18%13,518,068Mar 31, 2024
NEUBERGER BERMAN GROUP LLC0.16%0.00%468,652-249,062-34.70%5,520,720Mar 31, 2024

As of Mar 31 2024, Amicus Therapeutics's biggest institutional seller is MORGAN STANLEY. The company sold -3.62M shares of FOLD, valued at $114.32M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ABRDN PLC0.55%0.04%1,622,3991,622,399100.00%19,111,861Mar 31, 2024
GRANITE INVESTMENT PARTNERS, LLC0.31%0.41%918,834918,834100.00%10,823,865Mar 31, 2024
0.23%0.03%665,723665,723100.00%7,988,676Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.19%0.01%556,363556,363100.00%6,553,956Mar 31, 2024
OSTERWEIS CAPITAL MANAGEMENT INC0.16%0.33%484,060484,060100.00%5,702,227Mar 31, 2024
STEMPOINT CAPITAL LP0.14%0.03%400,000400,000100.00%120,000Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.08%0.33%226,723226,723100.00%2,670,797Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.05%0.00%144,500144,500100.00%1,702,210Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.03%0.00%101,899101,899100.00%1,200,370Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.03%0.00%101,623101,623100.00%1,197,119Mar 31, 2024
BARCLAYS PLC0.03%0.00%84,80084,800100.00%999,000Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.03%0.01%77,97677,976100.00%918,556Mar 31, 2024
CAPITAL FUND MANAGEMENT S.A.0.02%0.00%69,43169,431100.00%817,897Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.02%0.00%64,30064,300100.00%757,454Mar 31, 2024
EISLER CAPITAL (US) LLC0.02%0.02%60,38360,383100.00%711,312Mar 31, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.0.02%0.05%57,96657,966100.00%682,839Mar 31, 2024
BAYESIAN CAPITAL MANAGEMENT, LP0.02%0.06%50,20050,200100.00%591,356Mar 31, 2024
SHERBROOKE PARK ADVISERS LLC0.02%0.11%46,80246,802100.00%551,328Mar 31, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD0.01%0.06%43,99843,998100.00%518,000Mar 31, 2024
0.01%0.02%43,17843,178100.00%508,637Mar 31, 2024
MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC.0.01%0.03%31,59931,599100.00%372,236Mar 31, 2024
HSBC HOLDINGS PLC0.01%0.00%30,46430,464100.00%358,866Mar 31, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.01%0.09%29,46929,469100.00%347,145Mar 31, 2024
TWO SIGMA ADVISERS, LP0.01%0.00%24,57624,576100.00%289,505Mar 31, 2024
VERITION FUND MANAGEMENT LLC0.01%0.00%18,76718,767100.00%221,075Mar 31, 2024
CAPULA MANAGEMENT LTD0.01%0.00%17,00017,000100.00%200,260Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)0.01%0.00%16,48916,489100.00%194,240Mar 31, 2024
CERITY PARTNERS LLC0.01%0.00%16,15816,158100.00%190,339Mar 31, 2024
TRUIST FINANCIAL CORP0.00%0.00%14,29614,296100.00%168,407Mar 31, 2024
MML INVESTORS SERVICES, LLC0.00%0.00%10,52010,520100.00%124,000Mar 31, 2024
NVERSES CAPITAL, LLC0.00%0.16%5,6005,600100.00%65,968,000Mar 31, 2024
TORNO CAPITAL, LLC0.00%0.00%4,0004,000100.00%47,120Mar 31, 2024
PACER ADVISORS, INC.0.00%0.00%3,4683,468100.00%40,853Mar 31, 2024
STATE OF WYOMING0.00%0.01%3,1933,193100.00%37,614Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC0.00%0.00%2,7002,700100.00%31,806Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.00%-1,9591,959100.00%23,018,000Mar 31, 2024
MEEDER ASSET MANAGEMENT INC0.00%0.00%374374100.00%4,406Mar 31, 2024
JFS WEALTH ADVISORS, LLC0.00%0.00%282282100.00%3,322Mar 31, 2024
CONTINUUM ADVISORY, LLC-0.00%141141100.00%1,337,000Mar 31, 2024
GENEOS WEALTH MANAGEMENT INC.--6565100.00%766Mar 31, 2024

Amicus Therapeutics's largest new institutional shareholder by number of shares is ABRDN PLC, purchased 1.62M shares, valued at $19.11M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARTAL GROUP S.A.----2,500,000-100.00%-Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.----1,556,540-100.00%-Mar 31, 2024
FINEPOINT CAPITAL LP----1,489,025-100.00%-Mar 31, 2024
CUTTER CAPITAL MANAGEMENT, LP----947,418-100.00%-Mar 31, 2024
CAPTION MANAGEMENT, LLC----299,500-100.00%-Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC----295,500-100.00%-Mar 31, 2024
ALGERT GLOBAL LLC----184,540-100.00%-Mar 31, 2024
TWINBEECH CAPITAL LP----149,387-100.00%-Mar 31, 2024
JEFFERIES FINANCIAL GROUP INC.----143,700-100.00%-Mar 31, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.----110,665-100.00%-Mar 31, 2024
NATIXIS----47,250-100.00%-Mar 31, 2024
GROUP ONE TRADING, L.P.----33,514-100.00%-Mar 31, 2024
QUANTBOT TECHNOLOGIES LP----19,000-100.00%-Mar 31, 2024
GTS SECURITIES LLC----17,100-100.00%-Mar 31, 2024
CIPHER CAPITAL LP----16,162-100.00%-Mar 31, 2024
WOLVERINE TRADING, LLC----14,400-100.00%-Mar 31, 2024
OLD WELL PARTNERS, LLC----12,700-100.00%-Mar 31, 2024
BEIRNE WEALTH CONSULTING SERVICES, LLC----10,933-100.00%-Mar 31, 2024
CALTON & ASSOCIATES, INC.----10,011-100.00%-Mar 31, 2024
WALLEYE TRADING LLC----8,700-100.00%-Mar 31, 2024
RONALD BLUE TRUST, INC.----240-100.00%-Mar 31, 2024

Amicus Therapeutics's largest sold out institutional shareholder by shares sold is ARTAL GROUP S.A., sold -2.50M shares, valued at -, as of undefined.

Amicus Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Fiera Capital Series Trust6.55%130,471-4,759-3.52%Jun 30, 2023
Manager Directed Portfolios4.81%787,369--Jan 31, 2024
SPARROW FUNDS4.31%15,365--Feb 29, 2024
Elevation Series Trust1.15%56,54116,21840.22%Jan 31, 2024
WANGER ADVISORS TRUST1.09%683,804--Dec 31, 2023
HARTFORD HLS SERIES FUND II INC1.07%262,287-267,195-50.46%Dec 31, 2023
PRUDENTIAL SECTOR FUNDS, INC.0.78%1,618,012--Feb 29, 2024
HIGHLAND FUNDS II0.53%7,817--Dec 31, 2023
AMERICAN CENTURY MUTUAL FUNDS, INC.0.42%4,275,8492,069,73893.82%Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.41%201,243--Dec 31, 2023
TEKLA LIFE SCIENCES INVESTORS0.36%205,249--Dec 31, 2023
TEKLA HEALTHCARE INVESTORS0.34%382,028--Dec 31, 2023
T. Rowe Price Quantitative Management Funds, Inc.0.26%940,700--Dec 31, 2023
Voya EQUITY TRUST0.21%311,84847,62418.02%Feb 29, 2024
VANGUARD SPECIALIZED FUNDS0.18%10,154,8964,034,57565.92%Jan 31, 2024
BlackRock Health Sciences Trust II0.16%445,917--Dec 31, 2023
AMG FUNDS III0.16%26,052--Feb 29, 2024
Voya VARIABLE PRODUCTS TRUST0.14%43,731-799-1.79%Dec 31, 2023
PRIMECAP Odyssey Funds0.13%1,094,200--Jan 31, 2024
REYNOLDS FUNDS INC0.12%1,400--Mar 31, 2024
AMERICAN CENTURY VARIABLE PORTFOLIOS INC0.12%289,612-31,526-9.82%Dec 31, 2023
Humankind Benefit Corp0.11%2,34036818.66%Dec 31, 2023
FIDELITY ADVISOR SERIES VII0.10%835,800--Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.10%43,0739272.20%Dec 31, 2023
COLUMBIA ACORN TRUST0.09%318,538--Dec 31, 2023
DELAWARE GROUP EQUITY FUNDS V0.09%5,340,622-21,694-0.40%Feb 29, 2024
VICTORY VARIABLE INSURANCE FUNDS0.09%43,630-41,930-49.01%Dec 31, 2023
MFS SERIES TRUST I0.09%1,661,704154,08710.22%Feb 29, 2024
QUANTITATIVE MASTER SERIES LLC0.08%510,60135,0847.38%Dec 31, 2023
DEUTSCHE DWS GLOBAL/INTERNATIONAL FUND, INC.0.07%77,300--Feb 29, 2024
PRUDENTIAL JENNISON BLEND FUND, INC.0.07%43,553--Feb 29, 2024
DEUTSCHE DWS VARIABLE SERIES I0.07%29,421--Dec 31, 2023
VANGUARD INDEX FUNDS0.06%29,163,9805,219,74621.80%Dec 31, 2023
AIM GROWTH SERIES (INVESCO GROWTH SERIES)0.06%2,087,401--Dec 31, 2023
PRUDENTIAL JENNISON SMALL CO FUND, INC.0.05%253,143--Dec 29, 2023
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.05%191,82791,04990.35%Jan 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.04%8,035--Dec 29, 2023
FIDELITY SELECT PORTFOLIOS0.04%2,366,934311,13415.13%Feb 29, 2024
TIAA SEPARATE ACCOUNT VA 10.04%8,241--Dec 31, 2023
JNL VARIABLE FUND LLC0.03%177,847-12,868-6.75%Mar 31, 2020
WILLIAM BLAIR FUNDS0.03%2,539,790175,9507.44%Dec 31, 2023
FIDELITY CAPITAL TRUST0.03%295,300--Jan 31, 2024
Federated Hermes MDT Series0.03%63,016--Jan 31, 2024
JANUS INVESTMENT FUND0.02%7,424,720-2,444,548-24.77%Dec 31, 2023
Calvert Responsible Index Series, Inc.0.02%38,263--Dec 31, 2023
NEUBERGER BERMAN EQUITY FUNDS0.02%224,242-139,137-38.29%Feb 29, 2024
FIDELITY COMMONWEALTH TRUST0.02%71,0821,1471.64%Feb 29, 2024
VICTORY PORTFOLIOS0.02%666,750-466,910-41.19%Dec 31, 2023
RYDEX SERIES FUNDS0.02%84,970-4,580-5.11%Dec 31, 2023
ETFis Series Trust I0.02%26,2013,32414.53%Jan 31, 2024
Principal Exchange-Traded Funds0.02%199,05766,66350.35%Mar 31, 2024
ALPS ETF Trust0.02%202,813--Feb 29, 2024
PROFESSIONALLY MANAGED PORTFOLIOS0.02%86,053--Feb 29, 2024
FIDELITY SECURITIES FUND0.01%1,364,200--Jan 31, 2024
SunAmerica Specialty Series0.01%7,622-620-7.52%Apr 30, 2021
MFS VARIABLE INSURANCE TRUST0.01%442,083145,55549.09%Dec 31, 2023
Bernstein Fund Inc0.01%144,966--Dec 31, 2023
AMG Funds IV0.01%38,728--Jan 31, 2024
NEXPOINT FUNDS I0.01%48,800--Dec 31, 2023
Calvert Variable Products, Inc.0.01%29,4161,5555.58%Dec 31, 2023
Fidelity Commonwealth Trust II0.01%79,924--Aug 31, 2023
FIDELITY CONCORD STREET TRUST0.01%2,492,681142,5466.07%Feb 29, 2024
Guardian Variable Products Trust0.01%198,000--Dec 31, 2023
Gabelli Healthcare & WellnessRx Trust0.01%1,348--Dec 29, 2023
Voya VARIABLE PORTFOLIOS INC0.01%319,02971,75629.02%Dec 31, 2023
IndexIQ ETF Trust0.01%22,919--Jan 31, 2024
MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC0.01%5,4091,17027.60%Sep 30, 2020
DELAWARE VIP TRUST0.01%31,328--Dec 29, 2023
ProFunds0.01%88,66841,69588.76%Jan 31, 2024
HARBOR FUNDS0.01%197,537--Jan 31, 2024
RYDEX VARIABLE TRUST0.01%9,130-661-6.75%Dec 31, 2023
SSGA FUNDS0.01%3,261--Feb 29, 2024
SCHWAB STRATEGIC TRUST0.01%1,377,86181,5806.29%Feb 29, 2024
VANGUARD HORIZON FUNDS0.01%157,092--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.01%202,22912,3186.49%Dec 31, 2023
JPMORGAN TRUST II0.01%6,776,210--Feb 29, 2024
JPMORGAN INSURANCE TRUST0.01%84,220-3,480-3.97%Mar 31, 2023
VANGUARD EXPLORER FUND0.01%78,779--Jan 31, 2024
TIAA-CREF LIFE FUNDS0.01%17,1995,40145.78%Dec 31, 2023
Mutual of America Variable Insurance Portfolios, Inc.0.01%4,457-61-1.35%Sep 30, 2023
AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC0.01%78,77537,36390.22%Jan 31, 2024
FIDELITY COVINGTON TRUST0.01%75,452-7-0.01%Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.01%71,106-3,599-4.82%Dec 31, 2023
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.01%12,653--Dec 31, 2023
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.01%20,586--Dec 31, 2023
MUTUAL OF AMERICA INVESTMENT CORP0.01%217,85951,21930.74%Dec 31, 2023
MML SERIES INVESTMENT FUND0.01%48,533--Dec 31, 2023
Direxion Shares ETF Trust0.00%763,630207,43937.30%Jan 31, 2024
Securian Funds Trust0.00%48,099--Dec 31, 2023
VALIC Co II0.00%168,32514,3569.32%Feb 28, 2021
Segall Bryant & Hamill Trust0.00%87,062--Dec 31, 2023
ALLSPRING MASTER TRUST0.00%307,019-17,372-5.36%Feb 29, 2024
PFM Multi-Manager Series Trust0.00%3,300--Dec 31, 2023
Ivy Variable Insurance Portfolios0.00%91,7131,9212.14%Dec 29, 2023
AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST)0.00%917,452--Feb 29, 2024
HARTFORD SERIES FUND INC0.00%152,307--Dec 31, 2023
VANGUARD WORLD FUND0.00%791,15415,4511.99%Feb 29, 2024
DEUTSCHE DWS VARIABLE SERIES II0.00%7,094--Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%55,847--Feb 29, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%13,913-578-3.99%Dec 31, 2023

Amicus Therapeutics's largest mutual fund holder by % of total assets is "Fiera Capital Series Trust", owning 130.47K shares, compromising 6.55% of its total assets.

Amicus Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 242577.98%
31 Dec, 23238-0.83%
30 Sep, 232408.11%
30 Jun, 23222-2.20%
31 Mar, 23227-4.22%
31 Dec, 222373.49%
30 Sep, 222295.05%
30 Jun, 22218-1.36%
31 Mar, 22221-3.07%
31 Dec, 21228-8.80%
30 Sep, 212502.88%
30 Jun, 21243-9.67%
31 Mar, 21269-11.22%
31 Dec, 2030316.54%
30 Sep, 2026010.64%
30 Jun, 2023510.85%
31 Mar, 20212-7.02%
31 Dec, 192286.05%
30 Sep, 192150.47%
30 Jun, 19214-2.28%
31 Mar, 1921910.61%
31 Dec, 18198-8.33%
30 Sep, 18216-2.26%
30 Jun, 18221-3.07%
31 Mar, 182288.06%
31 Dec, 17211-4.09%
30 Sep, 1722034.97%
30 Jun, 171636.54%
31 Mar, 17153-0.65%
31 Dec, 161542.67%
30 Sep, 161507.91%
30 Jun, 16139-6.08%
31 Mar, 16148-1.99%
31 Dec, 15151-4.43%
30 Sep, 151586.04%
30 Jun, 1514911.19%
31 Mar, 1513417.54%
31 Dec, 1411411.76%
30 Sep, 1410264.52%
30 Jun, 1462-8.82%
31 Mar, 1468-
31 Dec, 1368-6.85%
30 Sep, 13735.80%
30 Jun, 136997.14%
31 Mar, 13359.38%
31 Dec, 12326.67%
30 Sep, 1230-6.25%
30 Jun, 123233.33%
31 Mar, 122414.29%
31 Dec, 11215.00%
30 Sep, 1120-4.76%
30 Jun, 112161.54%
31 Mar, 111344.44%
31 Dec, 109-
30 Sep, 109-35.71%
30 Jun, 1014-22.22%
31 Mar, 1018-
31 Dec, 091828.57%
30 Sep, 0914-12.50%
30 Jun, 091645.45%
31 Mar, 0911-21.43%
31 Dec, 0814-6.67%
30 Sep, 081566.67%
30 Jun, 089-25.00%
31 Mar, 0812-
31 Dec, 071220.00%
30 Sep, 071011.11%
30 Jun, 079-

As of 31 Mar 24, 257 institutions are holding Amicus Therapeutics's shares, representing an increase of 7.98% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 24317,126,407-0.42%
31 Dec, 23318,467,0047.53%
30 Sep, 23296,155,203-2.56%
30 Jun, 23303,931,0152.41%
31 Mar, 23296,782,1271.61%
31 Dec, 22292,069,0490.06%
30 Sep, 22291,891,550-4.30%
30 Jun, 22305,009,1020.63%
31 Mar, 22303,097,5110.70%
31 Dec, 21300,996,3282.72%
30 Sep, 21293,022,8766.00%
30 Jun, 21276,435,3370.20%
31 Mar, 21275,895,602-1.12%
31 Dec, 20279,014,1680.50%
30 Sep, 20277,636,849-1.29%
30 Jun, 20281,270,650-0.66%
31 Mar, 20283,150,2983.10%
31 Dec, 19274,634,2390.56%
30 Sep, 19273,102,3501.78%
30 Jun, 19268,336,0557.25%
31 Mar, 19250,195,7228.46%
31 Dec, 18230,680,6691.06%
30 Sep, 18228,260,2061.15%
30 Jun, 18225,670,9580.90%
31 Mar, 18223,660,5769.22%
31 Dec, 17204,777,2033.62%
30 Sep, 17197,629,57313.68%
30 Jun, 17173,851,2212.99%
31 Mar, 17168,807,8457.65%
31 Dec, 16156,818,5875.74%
30 Sep, 16148,308,7424.70%
30 Jun, 16141,647,0041.39%
31 Mar, 16139,702,4530.78%
31 Dec, 15138,617,2572.95%
30 Sep, 15134,644,79518.41%
30 Jun, 15113,711,31739.04%
31 Mar, 1581,785,9382.67%
31 Dec, 1479,655,30169.44%
30 Sep, 1447,011,68816.27%
30 Jun, 1440,432,96318.64%
31 Mar, 1434,080,552-0.46%
31 Dec, 1334,237,48715.16%
30 Sep, 1329,729,9500.33%
30 Jun, 1329,633,434180.50%
31 Mar, 1310,564,67521.78%
31 Dec, 128,675,15820.15%
30 Sep, 127,220,105-16.20%
30 Jun, 128,615,9619.43%
31 Mar, 127,873,322102.80%
31 Dec, 113,882,25129.06%
30 Sep, 113,008,207-21.99%
30 Jun, 113,856,08129.46%
31 Mar, 112,978,49999.72%
31 Dec, 101,491,325-22.46%
30 Sep, 101,923,239-54.41%
30 Jun, 104,218,909-11.51%
31 Mar, 104,767,717144.29%
31 Dec, 091,951,691133.66%
30 Sep, 09835,281-57.66%
30 Jun, 091,972,7393.19%
31 Mar, 091,911,740-67.19%
31 Dec, 085,826,72919.08%
30 Sep, 084,893,144187.70%
30 Jun, 081,700,792-54.76%
31 Mar, 083,759,65259.57%
31 Dec, 072,356,14336.86%
30 Sep, 071,721,56743.87%
30 Jun, 071,196,619-

Amicus Therapeutics (FOLD) has 317.13M shares outstanding as of 31 Mar 24, down -0.42% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 24107.44%0.93%
31 Dec, 23107.68%1.05%
30 Sep, 23101.15%0.93%
30 Jun, 23104.32%1.01%
31 Mar, 23101.87%1.00%
31 Dec, 22101.04%0.99%
30 Sep, 22100.92%0.92%
30 Jun, 22104.47%0.95%
31 Mar, 22105.07%0.83%
31 Dec, 21112.54%0.94%
30 Sep, 21109.56%1.02%
30 Jun, 21103.77%0.95%
31 Mar, 21104.36%0.90%
31 Dec, 20107.78%0.94%
30 Sep, 20107.13%0.90%
30 Jun, 20109.03%0.90%
31 Mar, 20110.19%0.96%
31 Dec, 19106.87%0.93%
30 Sep, 19107.24%0.84%
30 Jun, 19112.70%0.82%
31 Mar, 19117.18%0.76%
31 Dec, 18124.16%0.85%
30 Sep, 18120.67%0.84%
30 Jun, 18119.64%0.74%
31 Mar, 18127.10%0.71%
31 Dec, 17133.53%0.88%
30 Sep, 17122.91%0.83%
30 Jun, 17121.57%0.87%
31 Mar, 17118.24%0.87%
31 Dec, 16116.68%1.05%
30 Sep, 16105.44%0.88%
30 Jun, 16109.70%0.88%
31 Mar, 16111.60%0.91%
31 Dec, 15110.74%0.86%
30 Sep, 15113.41%0.88%
30 Jun, 15113.72%1.56%
31 Mar, 1585.42%1.02%
31 Dec, 1491.61%2.58%
30 Sep, 1459.59%1.65%
30 Jun, 1460.16%2.14%
31 Mar, 1452.96%1.87%
31 Dec, 1353.20%1.48%
30 Sep, 1359.91%1.68%
30 Jun, 1359.72%13.17%
31 Mar, 1321.29%5.87%
31 Dec, 1219.04%8.60%
30 Sep, 1214.88%4.40%
30 Jun, 1218.38%4.26%
31 Mar, 1220.78%16.48%
31 Dec, 1111.23%15.19%
30 Sep, 118.60%6.90%
30 Jun, 1111.17%14.98%
31 Mar, 118.63%29.86%
31 Dec, 105.38%11.09%
30 Sep, 106.96%2.98%
30 Jun, 1015.27%3.96%
31 Mar, 1019.63%26.38%
31 Dec, 098.63%63.27%
30 Sep, 093.69%4.85%
30 Jun, 098.72%12.20%
31 Mar, 098.45%1.26%
31 Dec, 0825.90%5.49%
30 Sep, 0821.73%37.92%
30 Jun, 087.57%2.69%
31 Mar, 0816.77%5.29%
31 Dec, 0717.80%10.52%
30 Sep, 0713.01%4.56%
30 Jun, 0716.89%-

As of 31 Mar 24, Amicus Therapeutics is held by 107.44% institutional shareholders, representing a 0.93% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 24132-
31 Dec, 231322.33%
30 Sep, 2312919.44%
30 Jun, 23108-12.90%
31 Mar, 23124-7.46%
31 Dec, 2213427.62%
30 Sep, 221059.38%
30 Jun, 22966.67%
31 Mar, 2290-5.26%
31 Dec, 2195-17.39%
30 Sep, 211151.77%
30 Jun, 21113-19.86%
31 Mar, 21141-
31 Dec, 2014122.61%
30 Sep, 20115-1.71%
30 Jun, 2011721.88%
31 Mar, 2096-29.41%
31 Dec, 1913611.48%
30 Sep, 19122-8.96%
30 Jun, 1913415.52%
31 Mar, 1911630.34%
31 Dec, 1889-18.35%
30 Sep, 181096.86%
30 Jun, 18102-18.40%
31 Mar, 1812520.19%
31 Dec, 17104-21.80%
30 Sep, 1713379.73%
30 Jun, 1774-9.76%
31 Mar, 1782-
31 Dec, 16826.49%
30 Sep, 1677-7.23%
30 Jun, 16837.79%
31 Mar, 1677-16.30%
31 Dec, 15923.37%
30 Sep, 1589-7.29%
30 Jun, 159624.68%
31 Mar, 1577-3.75%
31 Dec, 148019.40%
30 Sep, 1467109.38%
30 Jun, 143228.00%
31 Mar, 1425-24.24%
31 Dec, 1333-2.94%
30 Sep, 1334-38.18%
30 Jun, 1355139.13%
31 Mar, 132343.75%
31 Dec, 1216-
30 Sep, 1216-15.79%
30 Jun, 121911.76%
31 Mar, 1217112.50%
31 Dec, 118-27.27%
30 Sep, 1111-31.25%
30 Jun, 1116100.00%
31 Mar, 118100.00%
31 Dec, 104-33.33%
30 Sep, 10620.00%
30 Jun, 105-50.00%
31 Mar, 101011.11%
31 Dec, 09980.00%
30 Sep, 095-58.33%
30 Jun, 0912200.00%
31 Mar, 094-20.00%
31 Dec, 085-50.00%
30 Sep, 0810150.00%
30 Jun, 084-42.86%
31 Mar, 087-22.22%
31 Dec, 07950.00%
30 Sep, 076-33.33%
30 Jun, 079-

132 institutional shareholders have increased their position in FOLD stock as of 31 Mar 24 compared to 132 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 247722.22%
31 Dec, 23631.61%
30 Sep, 2362-15.07%
30 Jun, 237325.86%
31 Mar, 2358-6.45%
31 Dec, 2262-17.33%
30 Sep, 2275-
30 Jun, 2275-10.71%
31 Mar, 2284-
31 Dec, 21847.69%
30 Sep, 21782.63%
30 Jun, 2176-3.80%
31 Mar, 2179-17.71%
31 Dec, 20963.23%
30 Sep, 209329.17%
30 Jun, 2072-
31 Mar, 207235.85%
31 Dec, 1953-
30 Sep, 195351.43%
30 Jun, 1935-36.36%
31 Mar, 1955-14.06%
31 Dec, 18648.47%
30 Sep, 1859-13.24%
30 Jun, 186821.43%
31 Mar, 18561.82%
31 Dec, 175544.74%
30 Sep, 1738-17.39%
30 Jun, 174624.32%
31 Mar, 17375.71%
31 Dec, 1635-2.78%
30 Sep, 163628.57%
30 Jun, 1628-24.32%
31 Mar, 1637-
31 Dec, 1537-13.95%
30 Sep, 154322.86%
30 Jun, 1535-
31 Mar, 1535105.88%
31 Dec, 14176.25%
30 Sep, 1416-
30 Jun, 1416-38.46%
31 Mar, 142636.84%
31 Dec, 1319-13.64%
30 Sep, 1322266.67%
30 Jun, 13620.00%
31 Mar, 135-37.50%
31 Dec, 12814.29%
30 Sep, 127-12.50%
30 Jun, 128166.67%
31 Mar, 123-62.50%
31 Dec, 118100.00%
30 Sep, 11433.33%
30 Jun, 113-25.00%
31 Mar, 11433.33%
31 Dec, 10350.00%
30 Sep, 102-50.00%
30 Jun, 104100.00%
31 Mar, 102-60.00%
31 Dec, 09525.00%
30 Sep, 094-
30 Jun, 09433.33%
31 Mar, 093-40.00%
31 Dec, 08525.00%
30 Sep, 08433.33%
30 Jun, 083-25.00%
31 Mar, 084100.00%
31 Dec, 072-33.33%
30 Sep, 073-
30 Jun, 07--

77 institutional shareholders have reduced their position in FOLD stock as of 31 Mar 24 compared to 63 in the previous quarter (a 22.22% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 242577.98%317,126,407-0.42%107.44%0.93%132-7722.22%
31 Dec, 23238-0.83%318,467,0047.53%107.68%1.05%1322.33%631.61%
30 Sep, 232408.11%296,155,203-2.56%101.15%0.93%12919.44%62-15.07%
30 Jun, 23222-2.20%303,931,0152.41%104.32%1.01%108-12.90%7325.86%
31 Mar, 23227-4.22%296,782,1271.61%101.87%1.00%124-7.46%58-6.45%
31 Dec, 222373.49%292,069,0490.06%101.04%0.99%13427.62%62-17.33%
30 Sep, 222295.05%291,891,550-4.30%100.92%0.92%1059.38%75-
30 Jun, 22218-1.36%305,009,1020.63%104.47%0.95%966.67%75-10.71%
31 Mar, 22221-3.07%303,097,5110.70%105.07%0.83%90-5.26%84-
31 Dec, 21228-8.80%300,996,3282.72%112.54%0.94%95-17.39%847.69%
30 Sep, 212502.88%293,022,8766.00%109.56%1.02%1151.77%782.63%
30 Jun, 21243-9.67%276,435,3370.20%103.77%0.95%113-19.86%76-3.80%
31 Mar, 21269-11.22%275,895,602-1.12%104.36%0.90%141-79-17.71%
31 Dec, 2030316.54%279,014,1680.50%107.78%0.94%14122.61%963.23%
30 Sep, 2026010.64%277,636,849-1.29%107.13%0.90%115-1.71%9329.17%
30 Jun, 2023510.85%281,270,650-0.66%109.03%0.90%11721.88%72-
31 Mar, 20212-7.02%283,150,2983.10%110.19%0.96%96-29.41%7235.85%
31 Dec, 192286.05%274,634,2390.56%106.87%0.93%13611.48%53-
30 Sep, 192150.47%273,102,3501.78%107.24%0.84%122-8.96%5351.43%
30 Jun, 19214-2.28%268,336,0557.25%112.70%0.82%13415.52%35-36.36%
31 Mar, 1921910.61%250,195,7228.46%117.18%0.76%11630.34%55-14.06%
31 Dec, 18198-8.33%230,680,6691.06%124.16%0.85%89-18.35%648.47%
30 Sep, 18216-2.26%228,260,2061.15%120.67%0.84%1096.86%59-13.24%
30 Jun, 18221-3.07%225,670,9580.90%119.64%0.74%102-18.40%6821.43%
31 Mar, 182288.06%223,660,5769.22%127.10%0.71%12520.19%561.82%
31 Dec, 17211-4.09%204,777,2033.62%133.53%0.88%104-21.80%5544.74%
30 Sep, 1722034.97%197,629,57313.68%122.91%0.83%13379.73%38-17.39%
30 Jun, 171636.54%173,851,2212.99%121.57%0.87%74-9.76%4624.32%
31 Mar, 17153-0.65%168,807,8457.65%118.24%0.87%82-375.71%
31 Dec, 161542.67%156,818,5875.74%116.68%1.05%826.49%35-2.78%
30 Sep, 161507.91%148,308,7424.70%105.44%0.88%77-7.23%3628.57%
30 Jun, 16139-6.08%141,647,0041.39%109.70%0.88%837.79%28-24.32%
31 Mar, 16148-1.99%139,702,4530.78%111.60%0.91%77-16.30%37-
31 Dec, 15151-4.43%138,617,2572.95%110.74%0.86%923.37%37-13.95%
30 Sep, 151586.04%134,644,79518.41%113.41%0.88%89-7.29%4322.86%
30 Jun, 1514911.19%113,711,31739.04%113.72%1.56%9624.68%35-
31 Mar, 1513417.54%81,785,9382.67%85.42%1.02%77-3.75%35105.88%
31 Dec, 1411411.76%79,655,30169.44%91.61%2.58%8019.40%176.25%
30 Sep, 1410264.52%47,011,68816.27%59.59%1.65%67109.38%16-
30 Jun, 1462-8.82%40,432,96318.64%60.16%2.14%3228.00%16-38.46%
31 Mar, 1468-34,080,552-0.46%52.96%1.87%25-24.24%2636.84%
31 Dec, 1368-6.85%34,237,48715.16%53.20%1.48%33-2.94%19-13.64%
30 Sep, 13735.80%29,729,9500.33%59.91%1.68%34-38.18%22266.67%
30 Jun, 136997.14%29,633,434180.50%59.72%13.17%55139.13%620.00%
31 Mar, 13359.38%10,564,67521.78%21.29%5.87%2343.75%5-37.50%
31 Dec, 12326.67%8,675,15820.15%19.04%8.60%16-814.29%
30 Sep, 1230-6.25%7,220,105-16.20%14.88%4.40%16-15.79%7-12.50%
30 Jun, 123233.33%8,615,9619.43%18.38%4.26%1911.76%8166.67%
31 Mar, 122414.29%7,873,322102.80%20.78%16.48%17112.50%3-62.50%
31 Dec, 11215.00%3,882,25129.06%11.23%15.19%8-27.27%8100.00%
30 Sep, 1120-4.76%3,008,207-21.99%8.60%6.90%11-31.25%433.33%
30 Jun, 112161.54%3,856,08129.46%11.17%14.98%16100.00%3-25.00%
31 Mar, 111344.44%2,978,49999.72%8.63%29.86%8100.00%433.33%
31 Dec, 109-1,491,325-22.46%5.38%11.09%4-33.33%350.00%
30 Sep, 109-35.71%1,923,239-54.41%6.96%2.98%620.00%2-50.00%
30 Jun, 1014-22.22%4,218,909-11.51%15.27%3.96%5-50.00%4100.00%
31 Mar, 1018-4,767,717144.29%19.63%26.38%1011.11%2-60.00%
31 Dec, 091828.57%1,951,691133.66%8.63%63.27%980.00%525.00%
30 Sep, 0914-12.50%835,281-57.66%3.69%4.85%5-58.33%4-
30 Jun, 091645.45%1,972,7393.19%8.72%12.20%12200.00%433.33%
31 Mar, 0911-21.43%1,911,740-67.19%8.45%1.26%4-20.00%3-40.00%
31 Dec, 0814-6.67%5,826,72919.08%25.90%5.49%5-50.00%525.00%
30 Sep, 081566.67%4,893,144187.70%21.73%37.92%10150.00%433.33%
30 Jun, 089-25.00%1,700,792-54.76%7.57%2.69%4-42.86%3-25.00%
31 Mar, 0812-3,759,65259.57%16.77%5.29%7-22.22%4100.00%
31 Dec, 071220.00%2,356,14336.86%17.80%10.52%950.00%2-33.33%
30 Sep, 071011.11%1,721,56743.87%13.01%4.56%6-33.33%3-
30 Jun, 079-1,196,619-16.89%-9---

Amicus Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 03, 2024Campbell Bradley Ldirector, officer President and CEOS-SaleSell7,500$10.07$75.52K886,654
Apr 03, 2024Campbell Bradley Ldirector, officer President and CEOS-SaleSell7,500$11.67$87.50K886,654
Mar 15, 2024Crowley John Fdirector, officer Executive ChairmanS-SaleSell31,614$13.65$431.45K927,013

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 03, 2024Campbell Bradley Ldirector, officer President and CEOS-SaleSell7,500$10.07$75.52K886,654
May 03, 2024Campbell Bradley Ldirector, officer President and CEOM-ExemptSell7,500$8.61$64.57K52,500
Apr 16, 2024Prout Samanthaofficer Chief Accounting OfficerF-InKindSell7,027$10.66$74.91K73,926
Apr 03, 2024Campbell Bradley Ldirector, officer President and CEOS-SaleSell7,500$11.67$87.50K886,654
Apr 03, 2024Campbell Bradley Ldirector, officer President and CEOM-ExemptSell7,500$8.61$64.57K60,000
Mar 19, 2024Campbell Bradley Ldirector, officer President and CEOF-InKindSell13,375$11.48$153.54K886,654
Mar 15, 2024Campbell Bradley Ldirector, officer President and CEOF-InKindSell23,577$13.65$321.83K904,196
Mar 15, 2024Crowley John Fdirector, officer Executive ChairmanF-InKindSell36,865$13.65$503.21K958,627
Mar 15, 2024Crowley John Fdirector, officer Executive ChairmanS-SaleSell31,614$13.65$431.45K927,013
Mar 15, 2024Clark David Michaelofficer Chief People OfficerF-InKindSell8,614$13.65$117.58K271,775
Mar 15, 2024Castelli Jeffofficer Chief Development OfficerF-InKindSell10,005$13.65$136.57K377,205
Mar 15, 2024Rosenberg Ellenofficer Chief Legal OfficerF-InKindSell12,000$13.65$163.80K384,219

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 03, 2024Campbell Bradley Ldirector, officer President and CEOM-ExemptBuy7,500$8.61$64.57K894,154
May 03, 2024Campbell Bradley Ldirector, officer President and CEOS-SaleSell7,500$10.07$75.52K886,654
May 03, 2024Campbell Bradley Ldirector, officer President and CEOM-ExemptSell7,500$8.61$64.57K52,500
Apr 16, 2024Prout Samanthaofficer Chief Accounting OfficerF-InKindSell7,027$10.66$74.91K73,926
Apr 03, 2024Campbell Bradley Ldirector, officer President and CEOM-ExemptBuy7,500$8.61$64.57K894,154
Apr 03, 2024Campbell Bradley Ldirector, officer President and CEOS-SaleSell7,500$11.67$87.50K886,654
Apr 03, 2024Campbell Bradley Ldirector, officer President and CEOM-ExemptSell7,500$8.61$64.57K60,000
Mar 19, 2024Campbell Bradley Ldirector, officer President and CEOF-InKindSell13,375$11.48$153.54K886,654
Mar 15, 2024Campbell Bradley Ldirector, officer President and CEOA-AwardBuy28,810--927,773
Mar 15, 2024Campbell Bradley Ldirector, officer President and CEOF-InKindSell23,577$13.65$321.83K904,196
Mar 15, 2024Crowley John Fdirector, officer Executive ChairmanA-AwardBuy57,620--995,492
Mar 15, 2024Crowley John Fdirector, officer Executive ChairmanF-InKindSell36,865$13.65$503.21K958,627
Mar 15, 2024Crowley John Fdirector, officer Executive ChairmanS-SaleSell31,614$13.65$431.45K927,013
Mar 15, 2024Clark David Michaelofficer Chief People OfficerA-AwardBuy13,684--280,389
Mar 15, 2024Clark David Michaelofficer Chief People OfficerF-InKindSell8,614$13.65$117.58K271,775
Mar 15, 2024Castelli Jeffofficer Chief Development OfficerA-AwardBuy14,405--387,210
Mar 15, 2024Castelli Jeffofficer Chief Development OfficerF-InKindSell10,005$13.65$136.57K377,205
Mar 15, 2024Rosenberg Ellenofficer Chief Legal OfficerA-AwardBuy16,565--396,219
Mar 15, 2024Rosenberg Ellenofficer Chief Legal OfficerF-InKindSell12,000$13.65$163.80K384,219
Mar 11, 2024SBLENDORIO GLENNdirector-M-ExemptBuy15,000$2.80$42.00K83,596

The last insider sell of Amicus Therapeutics's stock was made by Campbell Bradley L on May 03 2024, selling 7,500 shares at $10.07 per share (valued at $75.52K).

Amicus Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20242540.00%
Q1 2024316547.69%
Q4 2023102343.48%
Q3 202393030.00%
Q2 20232115140.00%
Q1 2023255050.00%
Q4 202231520.00%
Q3 202231915.79%
Q2 20221515100.00%
Q1 2022202676.92%
Q4 202192339.13%
Q3 2021121963.16%
Q2 20214533136.36%
Q1 2021293974.36%
Q4 2020254358.14%
Q3 2020365565.45%
Q2 2020384192.68%
Q1 2020406759.70%
Q4 201971838.89%
Q3 20194666.67%

2 total buy trades, and 5 total sell trades (buy/sell ratio of 0.40%) were made by Amicus Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-2-
Q1 2024-22-
Q4 2023-17-
Q3 2023-12-
Q2 2023-10-
Q1 2023-18-
Q4 2022-9-
Q3 2022-13-
Q2 2022-11-
Q1 2022-4-
Q4 20212922.22%
Q3 202131030.00%
Q2 202151050.00%
Q1 202131225.00%
Q4 202031225.00%
Q3 202032114.29%
Q2 20201195.26%
Q1 2020-25-
Q4 2019-6-
Q3 20191333.33%

As of Q2 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Amicus Therapeutics's stocks.

Amicus Therapeutics Peer Ownership


TickerCompany
DNLIDenali Therapeutics Inc.
MLYSMineralys Therapeutics, Inc.
DICEDICE Therapeutics, Inc.
CRNXCrinetics Pharmaceuticals, Inc.
MREOMereo BioPharma Group plc
BMRNBioMarin Pharmaceutical Inc.
ARVNArvinas, Inc.
HRMYHarmony Biosciences Holdings, Inc.
INBXInhibrx, Inc.
ARGXargenx SE
DYNDyne Therapeutics, Inc.
EWTXEdgewise Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
RVMDRevolution Medicines, Inc. Warrant
INCYIncyte Corporation
LEGNLegend Biotech Corporation
BPMCBlueprint Medicines Corporation
KURAKura Oncology, Inc.
CYTKCytokinetics, Incorporated
KRTXKaruna Therapeutics, Inc.
RAREUltragenyx Pharmaceutical Inc.
AGIOAgios Pharmaceuticals, Inc.

FOLD Ownership FAQ


Amicus Therapeutics is owned by institutional shareholders (107.44%), insiders (0.75%), and public (-8.19%). The largest institutional shareholder of Amicus Therapeutics is VANGUARD GROUP INC (9.56% of total shares) and the top mutual fund owner is Fiera Capital Series Trust (6.55% of total shares).

Amicus Therapeutics's major institutional shareholders are VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, AVORO CAPITAL ADVISORS LLC, BLACKROCK INC., and WELLINGTON MANAGEMENT GROUP LLP. The top five shareholders own together 42.46% of the company's share outstanding.

As of Mar 2024, there are 257 institutional shareholders of Amicus Therapeutics.

VANGUARD GROUP INC owns 28.2M shares of Amicus Therapeutics, representing 9.56% of the company's total shares outstanding, valued at $332.25M (as of Mar 2024).

As of Mar 2024, PERCEPTIVE ADVISORS LLC holds 28.06M shares of Amicus Therapeutics (FOLD), compromising 9.51% of the company, valued at $330.52M.

AVORO CAPITAL ADVISORS LLC is the third largest holder of Amicus Therapeutics. The company owns 27.4M of the company's shares outstanding (worth $322.77M).